| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PTCT over the last quarter tilts toward selling: insiders offloaded a net 112,078 shares worth roughly $7.8M. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. Classified under Biotechnology (Health Care sector), PTCT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.29M | $77.68M | -5,000 | |
| CEO | 383.9K | $26.32M | - | |
| VP | 105.3K | $6.76M | -2,265 | |
| CFO | 84.0K | $6.75M | - | |
| VP | 79.1K | $5.38M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Utter Christine Marie58 | SVP, Chief Accounting Officer | Sell10b5-1 | 2,494 | $69.36 | $172,983.84 | -3.4% | +2.0% | - | |
| Feb 18, 2026 | Boulding Mark Elliott56 | Executive VP and CLO | Sale+OE10b5-1 | 5,894 | $69.33 | $408,612.61 | -5.2% | +2.0% | - | |
| Jan 12, 2026 | Pauwels Eric61 | Chief Business Officer | Sell10b5-1 | 7,348 | $77.02 | $565,946.00 | -8.4% | -9.2% | - | |
| Jan 9, 2026 | Boulding Mark Elliott56 | Executive VP and CLO | Sell10b5-1 | 6,347 | $77.06 | $489,080.53 | -5.4% | -8.6% | - | |
| Jan 8, 2026 | Golden Lee Scott | EVP &Chief Medical Officer | Sell10b5-1 | 866 | $76.45 | $66,205.70 | -0.9% | -7.3% | - | |
| Jan 8, 2026 | Almstead Neil Gregory55 | Chief Technical Ops Officer | Sell10b5-1 | 940 | $76.45 | $71,863.00 | -12.2% | -7.3% | - | |
| Jan 8, 2026 | Utter Christine Marie58 | SVP, Chief Accounting Officer | Sell10b5-1 | 1,034 | $76.45 | $79,049.30 | -1.4% | -7.3% | - | |
| Jan 8, 2026 | Klein Matthew B.53 | Chief Executive Officer | Sell10b5-1 | 2,514 | $76.45 | $192,195.30 | -0.6% | -7.3% | - | |
| Jan 7, 2026 | Boulding Mark Elliott56 | Executive VP and CLO | Sale+OE10b5-1 | 6,618 | $77.31 | $511,641.42 | -5.3% | -9.9% | - | |
| Jan 7, 2026 | Almstead Neil Gregory55 | Chief Technical Ops Officer | Sell10b5-1 | 2,411 | $77.19 | $186,097.79 | -26.0% | -9.9% | - |